Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -21.03x is 44% below its 5-year average of -14.58x, near the high end of its 5-year range (-13909.58x–-0.29x).
As of the fiscal period ended Tuesday, December 31, 2024. 99.25% above its 12-month average of -2804.45x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2024 (2024-12-31): -21.03x.
INTEREST COVERAGE RATIO
-21.03x
INTEREST COVERAGE RATIO AVG TTM
-2804.45x
INTEREST COVERAGE RATIO AVG 3Y
-24.78x
INTEREST COVERAGE RATIO AVG 5Y
-14.58x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+99.25%
CURRENT VS 3Y AVG
+15.13%
CURRENT VS 5Y AVG
-44.26%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.99x
median of 387 covered companies
CURRENT VS SECTOR MEDIAN
-321.49%
vs the sector median at left
Eupraxia Pharmaceuticals Inc.
Market Cap
$259.30M
Interest Coverage Ratio
-21.03x
TTM Avg
-2804.45x
3Y Avg
-24.78x
5Y Avg
-14.58x
Market Cap
$260.33M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$258.47M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$258.00M
Interest Coverage Ratio
-360.54x
TTM Avg
23.12x
3Y Avg
23.12x
5Y Avg
1139.56x
Market Cap
$257.09M
Interest Coverage Ratio
N/A
TTM Avg
130.06x
3Y Avg
93.86x
5Y Avg
75.34x
Market Cap
$254.52M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$250.48M
Interest Coverage Ratio
-530.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$271.27M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$272.91M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eupraxia Pharmaceuticals Inc. (EPRX) | $259.30M | -21.03x | -2804.45x | -24.78x | -14.58x |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $260.33M | N/A | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $258.47M | N/A | N/A | N/A | N/A |
| AC Immune S.A. (ACIU)vs › | $258.00M | -360.54x | 23.12x | 23.12x | 1139.56x |
| Anika Therapeutics, Inc. (ANIK)vs › | $257.09M | N/A | 130.06x | 93.86x | 75.34x |
| Century Therapeutics, Inc. (IPSC)vs › | $254.52M | N/A | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $250.48M | -530.37x | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE)vs › | $271.27M | N/A | N/A | N/A | N/A |
| Indaptus Therapeutics, Inc. (INDP)vs › | $272.91M | N/A | N/A | N/A | N/A |
| Aurora Cannabis Inc. (ACB)vs › | $275.95M | -25.79x | 0.59x | 0.59x | 0.59x |
Interest Coverage
-21.0x
Debt/Equity
0.01
Current Ratio
16.00
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-12-31 | -21.03x |
| 2024-09-30 | -13909.58x |
| 2024-06-30 | -23.26x |
| 2024-03-31 | -20.84x |
| 2023-12-31 | -47.55x |
| 2023-09-30 | -51.48x |
| 2023-06-30 | -18.92x |
| 2023-03-31 | -12.13x |
| 2022-12-31 | -19.01x |
| 2022-09-30 | -32.54x |
| 2022-06-30 | -24.23x |
| 2022-03-31 | -13.08x |
| 2021-12-31 | -13.33x |
| 2021-09-30 | -20.05x |
| 2021-06-30 | -27.03x |
| 2021-03-31 | -11.49x |
| 2020-12-31 | -0.29x |
| 2020-09-30 | -1.29x |
| 2020-06-30 | -1.35x |
| 2020-03-31 | -1.80x |
| 2019-12-31 | -0.76x |
| 2019-09-30 | -4.30x |
